Government Tender for Rate Contract of IHC-Flowcyto Antibodies 2026-2028 - Ahmedabad

This tender is issued by the Gujarat Cancer and Research Institute to establish a Rate Contract for the supply of IHC-Flowcyto Antibodies for the years 2026-2028. The goal is to procure high-quality antibodies essential for diagnostic and research activities related to cancer treatment, ensuring a steady supply at competitive prices over a 2-year period.

Interested vendors must register on the NProcure portal, download the tender documents, and submit their bids electronically before the deadline of 24-07-2026 at 17:00. Ensure all required documents, including tender fee, EMD, and technical certifications, are uploaded as per the specified formats. Participation also involves attending vendor training sessions if needed, which are organized regularly at the (n)Code Solutions office.

Bidders must have valid licenses, relevant experience in biomedical supply, and a minimum annual turnover of Rs. 5 Crore in the last three financial years. They must submit scanned copies of the tender fee, EMD, and other required documents during the preliminary stage. Certifications like ISO 9001 are preferred, and bidders should not be blacklisted by any government agency.

The antibodies should be monoclonal or polyclonal, with a purity of ≥ 95%, stored at 2-8°C, and have a minimum validity of 12 months. They must be CE or ISO certified. Samples will be evaluated for technical compliance, and detailed datasheets should be submitted during the technical stage.

The total estimated value for this tender is Rs. 2.20 Crore. The budget covers the supply of IHC-Flowcyto Antibodies over a 2-year period, with detailed pricing to be submitted in the bid proposal, including applicable taxes and charges. The contract aims to ensure continuous supply at competitive rates for Gujarat's public health sector.